Last reviewed · How we verify
NCT06683183
Ability of the Polar Wearables to Detect Fetal Heart Rate - Pilot Clinical Study
trial in Fetal Heart Rate Tracing in 11 participants. Completed in 11 April 2025.
11 April 2025
Quick facts
| Lead sponsor | Anna Axelin |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 11 |
| Start date | 19 February 2025 |
| Primary completion | 11 April 2025 |
| Estimated completion | 11 April 2025 |
| Sites | 1 location across Finland |
Conditions studied
- Fetal Heart Rate Tracing — all drugs for Fetal Heart Rate Tracing →
Sponsor
Anna Axelin
Who can join
Eligibility, female only, with Fetal Heart Rate Tracing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this clinical pilot study is 1. to evaluate the ability of the wearables to detect fetal heart rate 2. to evaluate the ability to distinguish the fetal ECG from the ECG of the mother The participating pregnant women will wear the Polar wearables (chest band, smart watch, arm band) for 15 minutes during of which, the data will be collected with all three wearables and patient monitor (reference device). The data from the wearables will be compared with the patient monitor data referred as golden standard. Background information will be collected with questionnaires from the participants. The data collection will be conducted in hospital environment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06683183
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Anna Axelin trials
Trials by the same sponsor.
- NCT06679127 — Validity and Feasibility of Newborn Bed Monitoring Device - a Clinical Pilot Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06683183 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anna Axelin
- Last refreshed: 18 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06683183.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing